AMINOSYN 7% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 7% W/ ELECTROLYTES is an injectable amino acid formulation with essential electrolytes designed for parenteral nutrition support. It provides balanced amino acids combined with magnesium chloride, potassium phosphate, and sodium chloride to meet nutritional requirements in patients unable to take nutrition orally. This product supplies nitrogen and electrolytes for maintenance and repletion in clinical settings.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), suggesting defensive commercial strategies and focus on manufacturing efficiency and cost management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Positions linked to AMINOSYN 7% emphasize operational excellence, manufacturing scale, and supply chain leadership rather than commercial growth or medical innovation. Career advancement on this product prioritizes technical expertise in parenteral formulation, quality systems, and hospital relationships.
EngineerQuality Inspector I
Worked on AMINOSYN 7% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.